Literature DB >> 20194235

Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.

Nathan Goldstein1, Melissa Carlson, Elayne Livote, Jean S Kutner.   

Abstract

BACKGROUND: Communication about the deactivation of implantable cardioverter-defibrillators (ICDs) in patients near the end of life is rare.
OBJECTIVE: To determine whether hospices are admitting patients with ICDs, whether such patients are receiving shocks, and how hospices manage ICDs.
DESIGN: Cross-sectional survey.
SETTING: Randomly selected hospice facilities. PARTICIPANTS: 900 hospices, 414 of which responded fully. MEASUREMENTS: Frequency of admission of patients with ICDs, frequency with which patients received shocks, existence of ICD deactivation policies, and frequency of deactivation.
RESULTS: 97% of hospices admitted patients with ICDs, and 58% reported that in the past year, a patient had been shocked. Only 10% of hospices had a policy that addressed deactivation. On average, 42% (95% CI, 37% to 48%) of patients with ICDs had the shocking function deactivated. LIMITATION: The study relied on the knowledge of hospice administrators.
CONCLUSION: Hospices are admitting patients with ICDs, and patients are being shocked at the end of life. Ensuring that hospices have policies in place to address deactivation may improve the care for patients with these devices. The authors provide a sample deactivation policy. PRIMARY FUNDING SOURCE: National Institute of Aging and National Institute of Nursing Research.

Entities:  

Mesh:

Year:  2010        PMID: 20194235      PMCID: PMC2832227          DOI: 10.7326/0003-4819-152-5-201003020-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

Review 1.  Quality of life and psychological functioning of icd patients.

Authors:  Samuel F Sears; Jamie B Conti
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

2.  End-of-life issues in intensive care units: a national random survey of nurses' knowledge and beliefs.

Authors:  K A Puntillo; P Benner; T Drought; B Drew; N Stotts; D Stannard; C Rushton; C Scanlon; C White
Journal:  Am J Crit Care       Date:  2001-07       Impact factor: 2.228

3.  Deactivation of automatic implantable cardioverter-defibrillators in hospice and home care patients at the end of life.

Authors:  Timothy W Kirk
Journal:  Home Healthc Nurse       Date:  2008 Jul-Aug

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population?

Authors:  D C Angus; M A Kelley; R J Schmitz; A White; J Popovich
Journal:  JAMA       Date:  2000-12-06       Impact factor: 56.272

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?

Authors:  Marion Eckert; Tina Jones
Journal:  Int J Nurs Pract       Date:  2002-06       Impact factor: 2.066

8.  Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization.

Authors:  J S Groeger; K K Guntupalli; M Strosberg; N Halpern; R C Raphaely; F Cerra; W Kaye
Journal:  Crit Care Med       Date:  1993-02       Impact factor: 7.598

9.  "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.

Authors:  Nathan E Goldstein; Davendra Mehta; Ezra Teitelbaum; Elizabeth H Bradley; R Sean Morrison
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

10.  "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.

Authors:  Nathan E Goldstein; Davendra Mehta; Saima Siddiqui; Ezra Teitelbaum; Jessica Zeidman; Magdelena Singson; Elena Pe; Elizabeth H Bradley; R Sean Morrison
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

View more
  35 in total

1.  A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data.

Authors:  Bryan C Wallace; Larry A Allen; Christopher E Knoepke; Russell E Glasgow; Carmen L Lewis; Diane L Fairclough; Laura J Helmkamp; Monica D Fitzgerald; Wendy S Tzou; Daniel B Kramer; Paul D Varosy; Sanjaya K Gupta; John M Mandrola; Scott C Brancato; Pamela N Peterson; Daniel D Matlock
Journal:  Am Heart J       Date:  2020-04-20       Impact factor: 4.749

2.  Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators.

Authors:  Patricia H Strachan; Sandra L Carroll; Sonya de Laat; Lisa Schwartz; Heather M Arthur
Journal:  J Palliat Care       Date:  2011       Impact factor: 2.250

3.  Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.

Authors:  Ariel R Green; Bruce Leff; Yongfei Wang; Erica S Spatz; Frederick A Masoudi; Pamela N Peterson; Stacie L Daugherty; Daniel D Matlock
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-12-29

4.  [Implantable cardioverter-defibrillator at the end of life].

Authors:  D Pfeiffer; A Hagendorff; C Kühne; S Reinhardt; N Klein
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-05-22

Review 5.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

Review 6.  Resynchronization: considering device-based cardiac therapy in older adults.

Authors:  Daniel B Kramer; Matthew R Reynolds; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2013-03-21       Impact factor: 5.562

7.  Decision-Making Experiences of Patients with Implantable Cardioverter Defibrillators.

Authors:  Ariel R Green; Amy Jenkins; Frederick A Masoudi; David J Magid; Jean S Kutner; Bruce Leff; Daniel D Matlock
Journal:  Pacing Clin Electrophysiol       Date:  2016-09-22       Impact factor: 1.976

8.  Palliative care consultations for heart failure patients: how many, when, and why?

Authors:  Marie Bakitas; Meredith Macmartin; Kenneth Trzepkowski; Alina Robert; Lisa Jackson; Jeremiah R Brown; James N Dionne-Odom; Alan Kono
Journal:  J Card Fail       Date:  2013-03       Impact factor: 5.712

9.  Availability of Heart Failure Medications in Hospice Care.

Authors:  Hillary D Lum; Carolyn Horney; David Koets; Jean S Kutner; Daniel D Matlock
Journal:  Am J Hosp Palliat Care       Date:  2015-08-31       Impact factor: 2.500

10.  Defibrillators, deactivation, decisions, and dying.

Authors:  Dan D Matlock; Larry A Allen
Journal:  JAMA Intern Med       Date:  2013-03-11       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.